Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 1:13 pm Sale | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 698,861 2% | -1,540,000![]() (-68.78%) | View |
2023-02-14 1:12 pm Unchanged | 13G | IDEAYA Biosciences, Inc. IDYA | Boxer Capital LLC | 2,202,812 4.6% | 0 (Unchanged) | View |
2023-02-14 1:10 pm Purchase | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 3,163,795 6.9% | 325,559![]() (+11.47%) | View |
2022-11-08 4:31 pm Purchase | 13D | Rain Oncology Inc. RAIN | Boxer Capital LLC | 2,510,127 9.99% | 615,935![]() (+32.52%) | View |
2022-09-19 4:30 pm Purchase | 13G | SpringWorks Therapeutics, Inc. SWTX | Boxer Capital LLC | 3,421,541 5.7% | 3,421,541![]() (New Position) | View |
2022-06-15 7:11 pm Unchanged | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,323,359 15.1% | 0 (Unchanged) | View |
2022-05-11 5:14 pm Sale | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 2,154,058 6.1% | -988,000![]() (-31.44%) | View |
2022-03-18 9:00 pm Sale | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,142,058 8.9% | -575,201![]() (-15.47%) | View |
2022-02-14 4:54 pm Sale | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,238,861 7.5% | -238,333![]() (-9.62%) | View |
2022-02-14 4:47 pm Unchanged | 13G | Atreca, Inc. BCEL | Boxer Capital LLC | 2,202,333 7.2% | 0 (Unchanged) | View |
2022-02-14 4:43 pm Sale | 13G | Matinas BioPharma Holdings, Inc. MTNB | Boxer Capital LLC | 0 0% | -11,478,634![]() (Position Closed) | View |
2022-02-14 4:40 pm Sale | 13G | Solid Biosciences Inc. SLDB | Boxer Capital LLC | 5,336,031 4.7% | -864,230![]() (-13.94%) | View |
2022-02-14 4:40 pm Sale | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 4,082,576 3.6% | -6,226,674![]() (-60.40%) | View |
2022-02-14 4:40 pm Sale | 13G | Cabaletta Bio, Inc. CABA | Boxer Capital LLC | 540,000 1.9% | -1,063,361![]() (-66.32%) | View |
2022-02-14 4:36 pm Sale | 13G | DBV Technologies S.A. DBVT | Boxer Capital LLC | 1,067,299 1.9% | -2,700,000![]() (-71.67%) | View |
2022-02-14 4:33 pm Sale | 13G | ARS Pharmaceuticals, Inc. SPRY | Boxer Capital LLC | 0 0% | -1,675,377![]() (Position Closed) | View |
2022-02-14 4:28 pm Sale | 13G | Marinus Pharmaceuticals, Inc. MRNS | Boxer Capital LLC | 0 0% | -4,800,000![]() (Position Closed) | View |
2022-02-14 4:22 pm Sale | 13G | CymaBay Therapeutics, Inc. CBAY | Boxer Capital LLC | 0 0% | -4,000,000![]() (Position Closed) | View |
2022-02-14 4:21 pm Sale | 13G | Elevation Oncology, Inc. ELEV | Boxer Capital LLC | 872,780 3.8% | -468,750![]() (-34.94%) | View |
2022-02-14 4:19 pm Sale | 13G | F-star Therapeutics, Inc. FSTX | Boxer Capital LLC | 0 0% | -1,501,428![]() (Position Closed) | View |